![](/img/cover-not-exists.png)
The irreversible ERBB1/2/4 inhibitor neratinib interacts with the PARP1 inhibitor niraparib to kill ovarian cancer cells
Booth, Laurence, Roberts, Jane L., Samuel, Peter, Avogadri-Connors, Francesca, Cutler, Richard E, Lalani, Alshad S., Poklepovic, Andrew, Dent, PaulLanguage:
english
Journal:
Cancer Biology & Therapy
DOI:
10.1080/15384047.2018.1436024
Date:
February, 2018
File:
PDF, 1.79 MB
english, 2018